Light therapy for treating moderate to severe acne on the face
Part of Skin clinical trials.
This study tests a new light-activated cream (photodynamic therapy) for moderate to severe facial acne. The cream is applied to the face and then activated with red light to target and reduce acne lesions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older.
- You have moderate to severe facial acne, with similar breakouts on both sides of your face.
- You have not used any oral acne treatments for at least 6 months.
- You have not used any topical (on the skin) acne treatments for at least 2 months.
- You are not pregnant or breastfeeding, and you are willing to avoid sun exposure or use sunscreen during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.
This study tests a cream containing ubiquinol, pomegranate peel extract, ceramide, and salicylic acid on people with mild-to-moderate acne. The goal is to see how it improves skin condition.
This early-stage study tests a new drug called TVB-3567, which may help treat acne. It checks the drug's safety and how the body processes it, first in healthy people and then in people with moderate to severe acne.
This study compares three different gels for treating mild to moderate acne on the face. One gel contains standard acne medication, another adds a steroid, and the third uses a special ingredient from stem cells (called secretome) to see which works best and is safest.
This trial tests a light-based device (IPL) to treat unwanted hair, acne, redness (rosacea), or age spots. It may help if you are an adult with one of these skin concerns and have a lighter skin type (not very dark). The treatment is quick and gentle, with little downtime.
This study tests a new medication called HB0043 for people with mild to moderate facial acne. It aims to see if the treatment is safe and effective in reducing acne.
Hear when a new Acne trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.